Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: Evolutionary considerations

Current Topics in Microbiology and Immunology

Volumn 374, Issue , 2013, Pages 81-108

  Szumowski, John D ^a   Adams, Kristin N ^a   Edelstein, Paul H ^b   Ramakrishnan, Lalita ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIINFECTIVE AGENT; CIPROFLOXACIN; ERYTHROMYCIN; ISONIAZID; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; VERAPAMIL;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL EFFLUX PUMP; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL GROWTH; DRUG RESISTANT TUBERCULOSIS; DRUG TOLERANCE; HUMAN; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CALCIUM CHANNEL BLOCKERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; EVOLUTION, MOLECULAR; GENE EXPRESSION; HUMANS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; TIME FACTORS; TUBERCULOSIS, PULMONARY; VERAPAMIL; VIRULENCE FACTORS;

EID: 84892755546     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2012-300     Document Type: Article

References (191)

1. Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L (2011) Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39-53. doi:10.1016/j.cell.2011.02.022
2. Aeschlimann JR, Kaatz GW, Rybak MJ (1999) The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in vitro infection model. J Antimicrob Chemother 44:343-349
3. Ahmed M, Borsch CM, Neyfakh AA, Schuldiner S (1993) Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J Biol Chem 268:11086-11089
4. Ainsa JA, Blokpoel MC, Otal I, Young DB, De Smet KA, Martin C (1998) Molecular cloning and characterization of tap, a putative multidrug efflux pump present in mycobacterium fortuitum and mycobacterium tuberculosis. J Bacteriol 180:5836-5843
5. Akira M, Sakatani M, Ishikawa H (2000) Transient radiographic progression during initial treatment of pulmonary tuberculosis: CT findings. J Comput Assist Tomogr 24:426-431
6. Amaral L, Boeree MJ, Gillespie SH, Udwadia ZF, van Soolingen D (2010) Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrob Agents 35:524-526. doi:10.1016/j.ijantimicag.2009.12.019
7. Asaduzzaman SM, Sonomoto K (2009) Lantibiotics: Diverse activities and unique modes of action. J Biosci Bioeng 107:475-487. doi:10.1016/j.jbiosc.2009. 01.003
8. Balganesh M, Dinesh N, Sharma S, Kuruppath S, Nair AV, Sharma U (2012) Efflux pumps of mycobacterium tuberculosis Play a significant role in antituberculosis activity of potential drug candidates. Antimicrob Agents Chemother 56:2643-2651. doi:10.1128/AAC.06003-11
9. Balganesh M, Kuruppath S, Marcel N, Sharma S, Nair A, Sharma U (2010) Rv1218c, an ABC transporter of mycobacterium tuberculosis with implications in drug discovery. Antimicrob Agents Chemother 54:5167-5172. doi:10.1128/AAC.00610- 10
10. Ball PR, Shales SW, Chopra I (1980) Plasmid-mediated tetracycline resistance in escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun 93:74-81
11. Barker J, Scaife H, Brown MR (1995) Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila. Antimicrob Agents Chemother 39:2684-2688
12. Bayer AS, Kupferwasser LI, Brown MH, Skurray RA, Grkovic S, Jones T, Mukhopadhay K, Yeaman MR (2006) Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activity. Antimicrob Agents Chemother 50:2448-2454. doi:10.1128/ AAC.00028-06
13. Bengoechea JA, Skurnik M (2000) Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in yersinia. Mol Microbiol 37:67-80
14. Beumer A, King D, Donohue M, Mistry J, Covert T, Pfaller S (2010) Detection of mycobacterium avium subsp. paratuberculosis in drinking water and biofilms by quantitative PCR. Appl Environ Microbiol 76:7367-7370. doi:10.1128/AEM.00730-10
15. Bianco MV, Blanco FC, Imperiale B, Forrellad MA, Rocha RV, Klepp LI, Cataldi AA, Morcillo N, Bigi F (2011) Role of P27-P55 operon from mycobacterium tuberculosis in the resistance to toxic compounds. BMC Infect Dis 11:195. doi:10.1186/1471-2334-11-195
16. Biet F, Boschiroli ML, Thorel MF, Guilloteau LA (2005) Zoonotic aspects of mycobacterium bovis and mycobacterium avium-intracellulare complex (MAC). Vet Res 36:411-436. doi:10.1051/vetres:2005001
17. Bigger J (1944) Treatment of staphylococcal infections with penicillin. Lancet 244:497-500
18. Bigi F, Gioffre A, Klepp L, Santangelo MP, Alito A, Caimi K, Meikle V, Zumarraga M, Taboga O, Romano MI, Cataldi A (2004) The knockout of the lprG-Rv1410 operon produces strong attenuation of mycobacterium tuberculosis. Microbes Infect Inst Pasteur 6:182-187. doi:10.1016/j.micinf.2003.10.010
19. Bina XR, Lavine CL, Miller MA, Bina JE (2008a) The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol Lett 279:226-233. doi:10.1111/j.1574-6968.2007.01033.x
20. Bina XR, Provenzano D, Nguyen N, Bina JE (2008b) Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect Immun 76:3595-3605. doi:10.1128/IAI.01620-07
21. Blair JM, Piddock LJ (2009) Structure, function and inhibition of RND efflux pumps in Gramnegative bacteria: An update. Curr Opin Microbiol 12:512-519. doi:10.1016/j.mib.2009.07.003
22. Bobrowitz ID (1980) Reversible roentgenographic progression in the initial treatment of pulmonary tuberculosis. Am Rev Respir Dis 121:735-742
23. Braibant M, Gilot P, Content J (2000) The ATP binding cassette (ABC) transport systems of mycobacterium tuberculosis. FEMS Microbiol Rev 24:449-467
24. Brissette CA, Lukehart SA (2007) Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola. Infect Immun 75:2307-2315. doi:10.1128/IAI.01718-06
25. Buckley AM, Webber MA, Cooles S, Randall LP, La Ragione RM, Woodward MJ, Piddock LJ (2006) The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 8:847-856. doi:10.1111/j.1462-5822.2005.00671.x
26. Bunikis I, Denker K, Ostberg Y, Andersen C, Benz R, Bergstrom S (2008) An RND-type efflux system in Borrelia burgdorferi is involved in virulence and resistance to antimicrobial compounds. PLoS Pathog 4:e1000009. doi:10.1371/journal.ppat.1000009
27. Camacho LR, Constant P, Raynaud C, Laneelle MA, Triccas JA, Gicquel B, Daffe M, Guilhot C (2001) Analysis of the phthiocerol dimycocerosate locus of mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J Biol Chem 276:19845-19854. doi:10.1074/jbc. M100662200
28. Camus JC, Pryor MJ, Medigue C, Cole ST (2002) Re-annotation of the genome sequence of mycobacterium tuberculosis H37Rv. Microbiology 148:2967-2973
29. Canetti G (1955) The tubercle bacillus in the pulmonary lesion of man, histobacteriology and its bearing on the therapy of pulmonary tuberculosis. Springer, New York
30. Cao CX, Silverstein SC, Neu HC, Steinberg TH (1992) J774 macrophages secrete antibiotics via organic anion transporters. J Infect Dis 165:322-328
31. Castelnuovo B (2010) A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci 10:320-324
32. Chan K, Knaak T, Satkamp L, Humbert O, Falkow S, Ramakrishnan L (2002) Complex pattern of mycobacterium marinum gene expression during long-term granulomatous infection. Proc Natl Acad Sci U S A 99:3920-3925. doi:10.1073/pnas.002024599
33. Chan YY, Chua KL (2005) The Burkholderia pseudomallei BpeAB-OprB efflux pump: Expression and impact on quorum sensing and virulence. J Bacteriol 187:4707-4719. doi:10.1128/JB.187.14.4707-4719.2005
34. Chauty A, Ardant MF, Adeye A, Euverte H, Guedenon A, Johnson C, Aubry J, Nuermberger E, Grosset J (2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 51:4029-4035. doi:10.1128/AAC.00175-07
35. Choudhuri BS, Bhakta S, Barik R, Basu J, Kundu M, Chakrabarti P (2002) Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrBofMycobacteriumtuberculosis. BiochemJ 367:279-285. doi:10.1042/BJ20020615
36. Clay H, Davis JM, Beery D, Huttenlocher A, Lyons SE, Ramakrishnan L (2007) Dichotomous role of the macrophage in early mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2:29-39. doi:10.1016/j.chom.2007. 06.004
37. Colangeli R, Helb D, Sridharan S, Sun J, Varma-Basil M, Hazbon MH, Harbacheuski R, Megjugorac NJ, Jacobs WR Jr, Holzenburg A, Sacchettini JC, Alland D (2005) The mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol Microbiol 55:1829-1840. doi:10.1111/ j.1365-2958.2005.04510.x
38. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, BarrellBG(1998) Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544. doi:10.1038/31159
39. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honore N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, QuailMA, Rajandream MA, RutherfordKM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG (2001) Massive gene decay in the leprosy bacillus. Nature 409:1007-1011. doi:10.1038/35059006
40. Connolly LE, Edelstein PH, Ramakrishnan L (2007) Why is long-term therapy required to cure tuberculosis? PLoS Med 4:e120. doi:10.1371/journal.pmed. 0040120
41. East African/British Medical Research Councils (1972) Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1:1079-1085
42. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council (1989) A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Am Rev Respir Dis 139:871-876
43. Cosma CL, Humbert O, Ramakrishnan L (2004) Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 5:828-835. doi:10.1038/ni1091
44. Cosma CL, Sherman DR, Ramakrishnan L (2003) The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 57:641-676. doi:10.1146/annurev. micro.57.030502.091033
45. Cox JS, Chen B, McNeil M, Jacobs WR Jr (1999) Complex lipid determines tissue-specific replication of mycobacterium tuberculosis in mice. Nature 402:79-83. doi:10.1038/47042
46. Coyne S, Courvalin P, Perichon B (2011) Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55:947-953. doi:10.1128/AAC.01388-10
47. Crimmins GT, Herskovits AA, Rehder K, Sivick KE, Lauer P, Dubensky TW Jr, Portnoy DA (2008) Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proc Natl Acad Sci U S A 105:10191-10196. doi:10.1073/pnas.0804170105
48. Curry JM, Whalan R, Hunt DM, Gohil K, Strom M, Rickman L, Colston MJ, Smerdon SJ, Buxton RS (2005) An ABC transporter containing a forkhead-associated domain interacts with a serine-threonine protein kinase and is required for growth of mycobacterium tuberculosis in mice. Infect Immun 73:4471-4477. doi:10.1128/IAI.73.8.4471-4477.2005
49. da Silva PE, Von Groll A, Martin A, Palomino JC (2011) Efflux as a mechanism for drug resistance in mycobacterium tuberculosis. FEMS Immunol Med Microbiol 63:1-9. doi:10.1111/j.1574-695X.2011.00831.x
50. Danilchanka O, Mailaender C, Niederweis M (2008) Identification of a novel multidrug efflux pump of mycobacterium tuberculosis. Antimicrob Agents Chemother 52:2503-2511. doi:10.1128/AAC.00298-08
51. Dannenberg AM Jr (1993) Immunopathogenesis of pulmonary tuberculosis. Hospital Practice 28:51-58
52. Dannenberg AM Jr (2003) Macrophage turnover, division and activation within developing, peak and ''healed'' tuberculous lesions produced in rabbits by BCG. Tuberculosis 83:251-260
53. De Rossi E, Arrigo P, Bellinzoni M, Silva PA, Martin C, Ainsa JA, Guglierame P, Riccardi G (2002) The multidrug transporters belonging to major facilitator superfamily in mycobacterium tuberculosis. Mol Med 8:714-724
54. DeMarco CE, Cushing LA, Frempong-Manso E, Seo SM, Jaravaza TA, Kaatz GW (2007) Effluxrelated resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 51:3235-3239. doi:10.1128/AAC.00430-07
55. Dhar N, McKinney JD (2007) Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol 10:30-38. doi:10.1016/j.mib.2006.12. 007
56. Dhawan VK, Yeaman MR, Cheung AL, Kim E, Sullam PM, Bayer AS (1997) Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun 65:3293-3299
57. Dianiskova P, Kordulakova J, Skovierova H, Kaur D, Jackson M, Brennan PJ, Mikusova K (2011) Investigation of ABC transporter from mycobacterial arabinogalactan biosynthetic cluster. Gen Physiol Biophys 30:239-250. doi:10.4149/gpb-2011-03-239
58. Ding Y, Onodera Y, Lee JC, Hooper DC (2008) NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J Bacteriol 190:7123-7129. doi:10.1128/JB.00655-08
59. Djoko KY, Franiek JA, Edwards JL, Falsetta ML, Kidd SP, Potter AJ, Chen NH, Apicella MA, Jennings MP, McEwan AG (2012) Phenotypic characterization of a copA mutant of Neisseria gonorrhoeae identifies a link between copper and nitrosative stress. Infect Immun 80: 1065-1071. doi:10.1128/IAI.06163-11
60. Doig KD, Holt KE, Fyfe JA, Lavender CJ, Eddyani M, Portaels F, Yeboah-Manu D, Pluschke G, Seemann T, Stinear TP (2012) On the origin of mycobacterium ulcerans, the causative agent of buruli ulcer. BMC Genomics 13:258. doi:10.1186/1471-2164-13-258
61. Domenech P, Reed MB, Barry CE 3rd (2005) Contribution of the mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect Immun 73:3492-3501. doi:10.1128/IAI.73.6.3492-3501.2005
62. Duits LA, Rademaker M, Ravensbergen B, van Sterkenburg MA, van Strijen E, Hiemstra PS, Nibbering PH (2001) Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids. Biochem Biophys Res Commun 280:522-525. doi:10.1006/bbrc.2000.4157
63. Ehrchen J, Steinmuller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M, Nordhues U, Sorg C, Sunderkotter C, Roth J (2007) Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109:1265-1274. doi:10.1182/blood-2006-02-001115
64. Escribano I, Rodriguez JC, Llorca B, Garcia-Pachon E, Ruiz M, Royo G (2007) Importance of the efflux pump systems in the resistance of mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 53:397-401. doi:10.1159/000109769
65. Falkinham JO 3rd (2010) Hospital water filters as a source of mycobacterium avium complex. J Med Microbiol 59:1198-1202. doi:10.1099/jmm.0. 022376-0
66. Falkinham JO 3rd, Norton CD, LeChevallier MW (2001) Factors influencing numbers of mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol 67:1225-1231
67. Farhana A, Kumar S, Rathore SS, Ghosh PC, Ehtesham NZ, Tyagi AK, Hasnain SE (2008) Mechanistic insights into a novel exporter-importer system of mycobacterium tuberculosis unravel its role in trafficking of iron. PLoS One 3:e2087. doi:10.1371/journal.pone.0002087
68. Ferhat M, Atlan D, Vianney A, Lazzaroni JC, Doublet P, Gilbert C (2009) The TolC protein of Legionella pneumophila plays a major role in multi-drug resistance and the early steps of host invasion. PLoS One 4:e7732. doi:10.1371/journal.pone.0007732
69. Frisk A, Schurr JR, Wang G, Bertucci DC, Marrero L, Hwang SH, Hassett DJ, Schurr MJ (2004) Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect Immun 72:5433-5438. doi:10.1128/IAI.72.9.5433-5438.2004
70. Garvey MI, Piddock LJ (2008) The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob Agents Chemother 52:1677-1685. doi:10.1128/AAC.01644-07
71. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, Small PL (1999) Mycolactone: A polyketide toxin from mycobacterium ulcerans required for virulence. Science 283:854-857
72. Grosset J (2003) Mycobacterium tuberculosis in the extracellular compartment: An underestimated adversary. Antimicrob Agents Chemother 47:833-836
73. World Health Organization (2011) Guidelines for the programmatic management of drugresistant tuberculosis, 2011 update
74. Gupta AK, Chauhan DS, Srivastava K, Das R, Batra S, Mittal M, Goswami P, Singhal N, Sharma VD, Venkatesan K, Hasnain SE, Katoch VM (2006) Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J Commun Dis 38:246-254
75. Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, Sharma VD (2010) Microarray analysis of efflux pump genes in multidrug-resistant mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microbial Drug Resist 16:21-28. doi:10.1089/mdr.2009.0054
76. Hagman KE, Pan W, Spratt BG, Balthazar JT, Judd RC, Shafer WM (1995) Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141(Pt 3):611-622
77. Hao P, Shi-Liang Z, Ju L, Ya-Xin D, Biao H, Xu W, Min-Tao H, Shou-Gang K, Ke W (2011) The role of ABC efflux pump, Rv1456c-Rv1457c-Rv1458c, from mycobacterium tuberculosis clinical isolates in China. Folia Microbiol 56:549-553. doi:10.1007/s12223-011-0080-7
78. Helling RB, Janes BK, Kimball H, Tran T, Bundesmann M, Check P, Phelan D, Miller C (2002) Toxic waste disposal in escherichia coli. J Bacteriol 184:3699-3703
79. Ho RH, Kim RB (2005) Transporters and drug therapy: Implications for drug disposition and disease. Clin Pharmacol Ther 78:260-277. doi:10.1016/j.clpt. 2005.05.011
80. Hobby GL, Meyer K, Chaffee E (1942) Observations on the mechanism of action of penicillin. Proc Soc Exp Biol Med 50:281-288
81. Jerse AE, Sharma ND, Simms AN, Crow ET, Snyder LA, Shafer WM (2003) A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect Immun 71:5576-5582
82. Jiang X, Zhang W, Zhang Y, Gao F, Lu C, Zhang X, Wang H (2008) Assessment of efflux pump gene expression in a clinical isolate mycobacterium tuberculosis by real-time reverse transcription PCR. Microbial Drug Resist 14:7-11. doi:10.1089/mdr.2008.0772
83. Jindani A, Aber VR, Edwards EA, Mitchison DA (1980) The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 121:939-949
84. Johnson JL, Hadad DJ, Dietze R, Maciel EL, Sewali B, Gitta P, Okwera A, Mugerwa RD, Alcaneses MR, Quelapio MI, Tupasi TE, Horter L, Debanne SM, Eisenach KD, Boom WH (2009) Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am J Respir Crit Care Med 180:558-563. doi:10.1164/rccm.200904-0536OC
85. Join-Lambert OF, Michea-HamzehpourM, Kohler T, Chau F, Faurisson F, Dautrey S, Vissuzaine C, Carbon C, Pechere J (2001) Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Antimicrob Agents Chemother 45:571-576. doi:10.1128/AAC.45.2.571-576.2001
86. Kaatz GW (2005) Bacterial efflux pump inhibition. Curr Opin Invest Drugs 6:191-198
87. Kalia NP, Mahajan P, Mehra R, Nargotra A, Sharma JP, Koul S, Khan IA (2012) Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus. J Antimicrob Chemother. doi:10.1093/jac/dks232
88. Klyachko KA, Schuldiner S, Neyfakh AA (1997) Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J Bacteriol 179:2189-2193
89. Kohler T, van Delden C, Curty LK, Hamzehpour MM, Pechere JC (2001) Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 183:5213-5222
90. Kraus D, Peschel A (2006) Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr Top Microbiol Immunol 306:231-250
91. Kumar D, Rao KV (2011) Regulation between survival, persistence, and elimination of intracellular mycobacteria: A nested equilibrium of delicate balances. Microb Infect/Inst Pasteur 13:121-133. doi:10.1016/j.micinf.2010.10. 009
92. Kupferwasser LI, Skurray RA, Brown MH, Firth N, Yeaman MR, Bayer AS (1999) Plasmidmediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: Role of the qacA locus. Antimicrob Agents Chemother 43:2395-2399
93. Lamarche MG, Deziel E (2011) MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursorHHQ (4-hydroxy-2-heptylquinoline). PLoS One 6:e24310. doi:10.1371/ journal.pone.0024310
94. Lamichhane G, Tyagi S, Bishai WR (2005) Designer arrays for defined mutant analysis to detect genes essential for survival of mycobacterium tuberculosis in mouse lungs. Infect Immun 73:2533-2540. doi:10.1128/IAI.73.4. 2533-2540.2005
95. Lamrabet O, Mba Medie F, Drancourt M (2012) Acanthamoeba polyphaga-enhanced growth of mycobacterium smegmatis. PLoS One 7:e29833. doi:10.1371/journal.pone.0029833
96. Larsson C, Luna B, Ammerman NC, Maiga M, Agarwal N, Bishai WR (2012) Gene expression of mycobacterium tuberculosis putative transcription factors whiB1-7 in redox environments. PLoS One 7:e37516. doi:10.1371/journal.pone.0037516
97. Lee A, Mao W, Warren MS, Mistry A, Hoshino K, Okumura R, Ishida H, Lomovskaya O (2000) Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 182:3142-3150
98. Leitner I, Nemeth J, Feurstein T, Abrahim A, Matzneller P, Lagler H, Erker T, Langer O, Zeitlinger M (2011) The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration. J Antimicrob Chemother 66:834-839. doi:10.1093/jac/dkq526
99. Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357-372. doi:10.1146/annurev.micro. 112408.134306
100. Li XZ, Nikaido H (2009) Efflux-mediated drug resistance in bacteria: An update. Drugs 69: 1555-1623. doi:10.2165/11317030-000000000-00000
101. Li XZ, Nikaido H, Poole K (1995) Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39:1948-1953
102. Lin J, Martinez A (2006) Effect of efflux pump inhibitors on bile resistance and in vivo colonization of Campylobacter jejuni. J Antimicrob Chemother 58:966-972. doi:10.1093/jac/ dkl374
103. Lin J, Sahin O, Michel LO, Zhang Q (2003) Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 71:4250-4259
104. Linares JF, Lopez JA, Camafeita E,Albar JP,Rojo F,Martinez JL (2005) Overexpression of themultidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol 187:1384-1391. doi:10.1128/JB.187.4.1384-1391.2005
105. Linell F, Norden A (1954) Mycobacterium balnei, a new acid fast bacillus occurring in swimming pools and capable of producing skin lesions in humans. Acta Tuberc Scand Suppl 33:1-84
106. Liu J, Takiff HE, Nikaido H (1996) Active efflux of fluoroquinolones in mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. J Bacteriol 178:3791-3795
107. Liu PT, Stenger S, Li H,Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J,Wu K,Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, HollisBW,Adams JS, BloomBR,Modlin RL (2006) Toll-like receptor triggering of a vitamin Dmediated human antimicrobial response. Science 311:1770-1773. doi:10.1126/science.1123933
108. Liu PT, Stenger S, Tang DH, Modlin RL (2007) Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179:2060-2063
109. Long Q, Zhou Q, Ji L, Wu J, Wang W, Xie J (2012) Mycobacterium smegmatis genomic characteristics associated with its saprophyte lifestyle. J Cell Biochem. doi:10.1002/jcb.24199
110. Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Hernandez-Pando R, McEvoy CR, Grobbelaar M, Murray M, van Helden PD, Victor TC (2011) Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant mycobacterium tuberculosis through efflux. Am J Respir Crit Care Med 184:269-276. doi:10.1164/rccm.201011-1924OC
111. Louw GE, Warren RM, Gey van Pittius NC, McEvoy CR, Van Helden PD, Victor TC (2009) A balancing act: Efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother 53:3181-3189. doi:10.1128/AAC.01577-08
112. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE (1995) Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 16:45-55
113. Machado D, Couto I, Perdigao J, Rodrigues L, Portugal I, Baptista P, Veigas B, Amaral L, Viveiros M (2012) Contribution of efflux to the emergence of isoniazid and multidrug resistance in mycobacterium tuberculosis. PLoS One 7:e34538. doi:10.1371/ journal.pone.0034538
114. Mandell GL, Bennett JE, Dolin R (2010) Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th edn. Churchill Livingstone/Elsevier, Philadelphia
115. Marquez B (2005) Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87: 1137-1147. doi:10.1016/j.biochi.2005.04.012
116. Martinez A, Lin J (2006) Effect of an efflux pump inhibitor on the function of the multidrug efflux pump CmeABC and antimicrobial resistance in campylobacter. Foodborne Pathog Dis 3: 393-402. doi:10.1089/fpd.2006.3.393
117. Martins M, Viveiros M, Amaral L (2008) Inhibitors of Ca2 ? and K ? transport enhance intracellular killing of M tuberculosis by non-killing macrophages. In vivo 22:69-75
118. McCune RM Jr, Tompsett R (1956) Fate of mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med 104: 737-762
119. McMurry L, Petrucci RE Jr, Levy SB (1980) Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in escherichia coli. Proc Natl Acad Sci U S A 77:3974-3977
120. Medjahed H, Gaillard JL, Reyrat JM (2010) Mycobacterium abscessus: A new player in the mycobacterial field. Trends Microbiol 18:117-123. doi:10.1016/j.tim.2009.12.007
121. Mitchison D, Davies G (2012) The chemotherapy of tuberculosis: Past, present and future. Int J Tuberc Lung Dis: Off J Int Union Against Tuberc Lung Dis 16:724-732. doi:10.5588/ ijtld.12.0083
122. Molle V, Soulat D, Jault JM, Grangeasse C, Cozzone AJ, Prost JF (2004) Two FHA domains on an ABC transporter, Rv1747, mediate its phosphorylation by PknF, a Ser/Thr protein kinase from mycobacterium tuberculosis. FEMS Microbiol Lett 234:215-223. doi:10.1016/ j.femsle.2004.03.033
123. Morris RP, Nguyen L, Gatfield J (2005) Ancestral antibiotic resistance in mycobacterium tuberculosis. Proc Natl Acad Sci USA 102(34):12200-12205
124. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B (2012) Mycobacterium abscessus: A new antibiotic nightmare. J Antimicrob Chemother 67:810-818. doi:10.1093/jac/dkr578
125. Neyfakh AA (2002) Mystery of multidrug transporters: The answer can be simple. Mol Microbiol 44:1123-1130
126. Nishino K, Latifi T, Groisman EA (2006) Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar typhimurium. Mol Microbiol 59:126-141. doi:10.1111/j.1365-2958.2005.04940.x
127. Ordonez E, Letek M, Valbuena N, Gil JA, Mateos LM (2005) Analysis of genes involved in arsenic resistance in Corynebacterium glutamicum ATCC 13032. Appl Environ Microbiol 71:6206-6215. doi:10.1128/AEM.71.10.6206-6215.2005
128. Padilla E, Llobet E, Domenech-Sanchez A, Martinez-Martinez L, Bengoechea JA, Alberti S (2010) Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 54:177-183. doi:10.1128/AAC.00715-09
129. Pages JM, Amaral L (2009) Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 1794: 826-833. doi:10.1016/j.bbapap.2008.12.011
130. Parker D, Prince A (2011) Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 45:189-201. doi:10.1165/rcmb.2011-0011RT
131. Pasca MR, Guglierame P, Arcesi F, Bellinzoni M, De Rossi E, Riccardi G (2004) Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in mycobacterium Tuberculosis. Antimicrob Agents Chemother 48:3175-3178. doi:10.1128/AAC.48.8.3175-3178.2004
132. Pasca MR, Guglierame P, De Rossi E, Zara F, Riccardi G (2005) mmpL7 gene of mycobacterium tuberculosis is responsible for isoniazid efflux in mycobacterium smegmatis. Antimicrob Agents Chemother 49:4775-4777. doi:10.1128/AAC.49.11.4775-4777.2005
133. Perez A, Poza M, Fernandez A, Fernandez Mdel C, Mallo S, Merino M, Rumbo-Feal S, Cabral MP, Bou G (2012) Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother 56:2084-2090. doi:10.1128/ AAC.05509-11
134. Piddock LJ (2006a) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382-402. doi:10.1128/CMR.19.2.382-402.2006
135. Piddock LJ (2006b) Multidrug-resistance efflux pumps -not just for resistance. Nat Rev Microbiol 4:629-636. doi:10.1038/nrmicro1464
136. Pierre-Audigier C, Jouanguy E, Lamhamedi S, Altare F, Rauzier J, Vincent V, Canioni D, Emile JF, Fischer A, Blanche S, Gaillard JL, Casanova JL (1997) Fatal disseminated mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America 24:982-984
137. Platz GJ, Bublitz DC, Mena P, Benach JL, Furie MB, Thanassi DG (2010) A tolC mutant of Francisella tularensis is hypercytotoxic compared to the wild type and elicits increased proinflammatory responses from host cells. Infect Immun 78:1022-1031. doi:10.1128/ IAI.00992-09
138. Posadas DM, Martin FA, Sabio y Garcia JV, Spera JM, Delpino MV, Baldi P, Campos E, Cravero SL, Zorreguieta A (2007) The TolC homologue of Brucella suis is involved in resistance to antimicrobial compounds and virulence. Infect Immun 75:379-389. doi:10.1128/IAI.01349-06
139. Quillin SJ, Schwartz KT, Leber JH (2011) The novel Listeria monocytogenes bile sensor BrtA controls expression of the cholic acid efflux pump MdrT. Mol Microbiol 81:129-142. doi:10.1111/j.1365-2958.2011.07683.x
140. Ramakrishnan L, Federspiel NA, Falkow S (2000) Granuloma-specific expression of mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288:1436-1439
141. Ramon-Garcia S, Martin C, Thompson CJ, Ainsa JA (2009) Role of the mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother 53:3675-3682. doi:10.1128/AAC.00550-09
142. Reddy TB, Riley R, Wymore F, Montgomery P, DeCaprio D, Engels R, Gellesch M, Hubble J, Jen D, Jin H, Koehrsen M, Larson L, Mao M, Nitzberg M, Sisk P, Stolte C, Weiner B, White J, Zachariah ZK, Sherlock G, Galagan JE, Ball CA, Schoolnik GK (2009) TB database: An integrated platform for tuberculosis research. Nucleic Acids Res 37:D499-D508. doi:10.1093/nar/gkn652
143. Rengarajan J, Bloom BR, Rubin EJ (2005) Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci USA 102: 8327-8332. doi:10.1073/pnas.0503272102
144. Richter E, Rusch-Gerdes S, Hillemann D (2007) First linezolid-resistant clinical isolates of mycobacterium tuberculosis. Antimicrob Agents Chemother 51:1534-1536. doi:10.1128/ AAC.01113-06
145. Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, Macheras E, Heym B, Herrmann JL, Daffe M, Brosch R, Risler JL, Gaillard JL (2009) Non mycobacterial virulence genes in the genome of the emerging pathogen mycobacterium abscessus. PLoS ONE 4:e5660. doi:10.1371/journal.pone.0005660
146. Rodrigues L, Ainsa JA, Amaral L, Viveiros M (2011a) Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors. Recent Pat Anti-Infect Drug Discovery 6:118-127
147. Rodrigues L, Machado D, Couto I, Amaral L, Viveiros M (2011b) Contribution of efflux activity to isoniazid resistance in the mycobacterium tuberculosis complex. Infection, genetics and evolution: Journal of molecular epidemiology and evolutionary genetics in infectious diseases. doi:10.1016/j.meegid.2011.08.009
148. Rodrigues L, Machado D, Couto I, Amaral L, Viveiros M (2012) Contribution of efflux activity to isoniazid resistance in the mycobacterium tuberculosis complex. Infection, genetics and evolution: Journal of molecular epidemiology and evolutionary genetics in infectious diseases 12:695-700. doi:10.1016/j.meegid.2011.08.009
149. Rodrigues LC, Lockwood D (2011) Leprosy now: Epidemiology, progress, challenges, and research gaps. Lancet Infect Dis 11:464-470. doi:10.1016/S1473-3099(11)70006-8
150. Rohde KH, Veiga DF, Caldwell S, Balazsi G, Russell DG (2012) Linking the transcriptional profiles and the physiological states of mycobacterium tuberculosis during an extended intracellular infection. PLoS Pathog 8:e1002769. doi:10.1371/journal.ppat.1002769
151. Rosenberg EY, Bertenthal D, Nilles ML, Bertrand KP, Nikaido H (2003) Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with rob regulatory protein. Mol Microbiol 48:1609-1619
152. Saier MH Jr, Yen MR, Noto K, Tamang DG, Elkan C (2009) The transporter classification database: Recent advances. Nucleic Acids Res 37:D274-D278. doi:10.1093/nar/gkn862
153. Sassetti CM, Rubin EJ (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 100:12989-12994. doi:10.1073/pnas.2134250100
154. Schaefer WB (1954) The effect of isoniazid on growing and resting tubercle bacilli. Am Rev Tuberc 69:125-127
155. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK (2003) Transcriptional adaptation of mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment. J Exp Med 198:693-704. doi:10.1084/jem.20030846 jem.20030846 [pii]
156. Shafer WM, Balthazar JT, Hagman KE, Morse SA (1995) Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology 141(Pt 4):907-911
157. Shafer WM, Qu X, Waring AJ, Lehrer RI (1998) Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/ nodulation/division efflux pump family. Proc Natl Acad Sci USA 95:1829-1833
158. Sharma S, Kumar M, Nargotra A, Koul S, Khan IA (2010) Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of mycobacterium tuberculosis. J Antimicrob Chemother 65:1694-1701. doi:10.1093/jac/dkq186
159. Shepard CC (1957) Growth characteristics of tubercle bacilli and certain other mycobacteria in HeLa cells. J Exp Med 105:39-48
160. Siddiqi N, Das R, Pathak N, Banerjee S, Ahmed N, Katoch VM, Hasnain SE (2004) Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 32:109-111. doi:10.1007/s15010- 004-3097-x
161. Simeone R, Bobard A, Lippmann J, Bitter W, Majlessi L, Brosch R, Enninga J (2012) Phagosomal rupture by mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog 8:e1002507. doi:10.1371/journal.ppat.1002507
162. Singh M, Jadaun GP, Ramdas, Srivastava K, Chauhan V, Mishra R, Gupta K, Nair S, Chauhan DS, Sharma VD, Venkatesan K, Katoch VM (2011) Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant mycobacterium tuberculosis isolates. Indian J Med Res 133:535-540
163. Singh P, Cole ST (2011) Mycobacterium leprae: Genes, pseudogenes and genetic diversity. Future Microbiol 6:57-71. doi:10.2217/fmb.10.153
164. Spies FS, da Silva PE, Ribeiro MO, Rossetti ML, Zaha A (2008) Identification of mutations related to streptomycin resistance in clinical isolates of mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob Agents Chemother 52:2947-2949. doi:10.1128/AAC.01570-07
165. Spivey VL, Molle V, Whalan RH, Rodgers A, Leiba J, Stach L, Walker KB, Smerdon SJ, Buxton RS (2011) Forkhead-associated (FHA) domain containing ABC transporter Rv1747 is positively regulated by Ser/Thr phosphorylation in mycobacterium tuberculosis. J Biol Chem 286:26198-26209. doi:10.1074/jbc.M111. 246132
166. Srinivasan K (2007) Black pepper and its pungent principle-piperine: A review of diverse physiological effects. Crit Rev Food Sci Nutr 47:735-748. doi:10.1080/10408390601062054
167. Srivastava S, Musuka S, Sherman C, Meek C, Leff R, Gumbo T (2010) Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol. J Infect Dis 201:1225-1231. doi:10.1086/651377
168. Stamm LM, Morisaki JH, Gao LY, Jeng RL, McDonald KL, Roth R, Takeshita S, Heuser J, Welch MD, Brown EJ (2003) Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility. J Exp Med 198:1361-1368. doi:10.1084/jem.20031072
169. Stinear TP, Seemann T,Harrison PF, JenkinGA,Davies JK, Johnson PD, Abdellah Z, Arrowsmith C, Chillingworth T, Churcher C, Clarke K, Cronin A, Davis P, Goodhead I, Holroyd N, Jagels K, Lord A, Moule S,Mungall K, Norbertczak H, Quail MA, Rabbinowitsch E, Walker D, White B, Whitehead S, Small PL, Brosch R, Ramakrishnan L, Fischbach MA, Parkhill J, Cole ST (2008) Insights from the complete genome sequence of mycobacterium marinum on the evolution of mycobacterium tuberculosis. Genome Res 18:729-741. doi:10.1101/gr.075069.107
170. Stone BJ, Miller VL (1995) Salmonella enteritidis has a homologue of tolC that is required for virulence in BALB/c mice. Mol Microbiol 17:701-712
171. Taylor DL, Bina XR, Bina JE (2012) Vibrio cholerae VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus. PLoS One 7:e38208. doi:10.1371/journal.pone. 0038208
172. Tekaia F, Gordon SV, Garnier T, Brosch R, Barrell BG, Cole ST (1999) Analysis of the proteome of mycobacterium tuberculosis in silico. Tuber Lung Dis 79:329-342
173. Thanassi DG, Cheng LW, Nikaido H (1997) Active efflux of bile salts by Escherichia coli. J Bacteriol 179:2512-2518
174. Tsukamura M (1976) Properties of mycobacterium smegmatis freshly isolated from soil. Japan J Microbiol 20:355-356
175. Tzeng YL, Ambrose KD, Zughaier S, Zhou X, Miller YK, Shafer WM, Stephens DS (2005) Cationic antimicrobial peptide resistance in Neisseria meningitidis. J Bacteriol 187: 5387-5396. doi:10.1128/JB.187.15.5387-5396.2005
176. van der Wel N, Hava D, Houben D, Fluitsma D, van Zon M, Pierson J, Brenner M, Peters PJ (2007) M tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129:1287-1298. doi:10.1016/j.cell.2007.05.059
177. Viveiros M, Portugal I, Bettencourt R, Victor TC, Jordaan AM, Leandro C, Ordway D, Amaral L (2002) Isoniazid-induced transient high-level resistance in mycobacterium tuberculosis. Antimicrob Agents Chemother 46:2804-2810
178. Wallace RJ Jr, Nash DR, Tsukamura M, Blacklock ZM, Silcox VA (1988) Human disease due to Mycobacterium smegmatis. J Infect Dis 158:52-59
179. Wallis RS, Patil S, Cheon SH, Edmonds K, Phillips M, Perkins MD, Joloba M, Namale A, Johnson JL, Teixeira L, Dietze R, Siddiqi S, Mugerwa RD, Eisenach K, Ellner JJ (1999) Drug tolerance in mycobacterium tuberculosis. Antimicrob Agents Chemother 43:2600-2606
180. Wansbrough-Jones M, Phillips R (2006) Buruli ulcer: Emerging from obscurity. Lancet 367:1849-1858. doi:10.1016/S0140-6736(06)68807-7
181. Ward SK, Abomoelak B, Hoye EA, Steinberg H, Talaat AM (2010) CtpV: A putative copper exporter required for full virulence of mycobacterium tuberculosis. Mol Microbiol 77: 1096-1110. doi:10.1111/j.1365-2958.2010.07273.x
182. Warner DM, Levy SB (2010) Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Robdependent CAMP induction of the marRAB operon. Microbiology 156:570-578. doi:10.1099/ mic.0.033415-0
183. Warner DM, Shafer WM, Jerse AE (2008) Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 70:462-478. doi:10.1111/j.1365-2958.2008.06424.x
184. Woodward JJ, Iavarone AT, Portnoy DA (2010) c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328:1703-1705. doi:10.1126/science.1189801
185. Woolridge DP, Vazquez-Laslop N, Markham PN, Chevalier MS, Gerner EW, Neyfakh AA (1997) Efflux of the natural polyamine spermidine facilitated by the Bacillus subtilis multidrug transporter Blt. The Journal of biological chemistry 272:8864-8866
186. Wu Y, Vulic M, Keren I, Lewis K (2012) Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother. doi:10.1128/AAC.00921-12
187. Yamazaki Y, Danelishvili L, Wu M, Hidaka E, Katsuyama T, Stang B, Petrofsky M, Bildfell R, Bermudez LE (2006) The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells. Cell Microbiol 8:806-814. doi:10.1111/j.1462-5822.2005.00667.x
188. Yanong RP, Pouder DB, Falkinham JO 3rd (2010) Association of mycobacteria in recirculating aquaculture systems and mycobacterial disease in fish. J Aquat Anim Health 22:219-223. doi:10.1577/H10-009.1
189. Zahner D, Zhou X, Chancey ST, Pohl J, Shafer WM, Stephens DS (2010) Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 54:3516-3519. doi:10.1128/AAC.01756-09
190. Zhang M, Yue J, Yang YP, Zhang HM, Lei JQ, Jin RL, Zhang XL, Wang HH (2005) Detection of mutations associated with isoniazid resistance in mycobacterium tuberculosis isolates from China. J Clin Microbiol 43:5477-5482. doi:10.1128/JCM.43.11.5477-5482.2005
191. Zierski M, Bek E, Long MW, Snider DE Jr (1980) Short-course (6 month) cooperative tuberculosis study in Poland: Results 18 months after completion of treatment. Am Rev Respir Dis 122:879-889